Comment
. 2005 Nov;49(11):4816; author reply 4816-7.
doi: 10.1128/AAC.49.11.4816-4817.2005.
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
- PMID: 16251343
- PMCID: PMC1280171
- DOI: 10.1128/AAC.49.11.4816-4817.2005
Item in Clipboard
Comment
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Antimicrob Agents Chemother.
2005 Nov.
No abstract available
Comment on
-
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6. doi: 10.1128/AAC.49.6.2260-2266.2005. Antimicrob Agents Chemother. 2005. PMID: 15917519 Free PMC article. Clinical Trial.
Similar articles
-
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.Curr Med Res Opin. 2010 Mar;26(3):571-88. doi: 10.1185/03007990903512057. Curr Med Res Opin. 2010. PMID: 20055750 Review.
-
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).Int J Antimicrob Agents. 2005 Dec;26(6):442-8. doi: 10.1016/j.ijantimicag.2005.09.003. Epub 2005 Nov 10. Int J Antimicrob Agents. 2005. PMID: 16289514 Clinical Trial.
-
Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?Antimicrob Agents Chemother. 2006 May;50(5):1910; author reply 1910-1. doi: 10.1128/AAC.50.5.1910-1911.2006. Antimicrob Agents Chemother. 2006. PMID: 16641477 Free PMC article. No abstract available.
-
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6. doi: 10.1128/AAC.49.6.2260-2266.2005. Antimicrob Agents Chemother. 2005. PMID: 15917519 Free PMC article. Clinical Trial.
-
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.Int J Clin Pract. 2009 Mar;63(3):376-86. doi: 10.1111/j.1742-1241.2008.01958.x. Int J Clin Pract. 2009. PMID: 19222624 Review.
Cited by
-
Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).Curr Infect Dis Rep. 2012 Jun;14(3):330-8. doi: 10.1007/s11908-012-0254-8. Curr Infect Dis Rep. 2012. PMID: 22430229
-
Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.J Clin Microbiol. 2008 Sep;46(9):3042-7. doi: 10.1128/JCM.00265-08. Epub 2008 Jul 2. J Clin Microbiol. 2008. PMID: 18596146 Free PMC article.
References
-
- Charles, P. G. P., P. B. Ward, P. D. R. Johnson, B. P. Howden, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448-451. - PubMed
-
- Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155. - PubMed
-
- Howden, B. P., P. B. Ward, P. D. R. Johnson, P. G. P. Charles, and M. L. Grayson. 2005. Low-level vancomycin resistance in Staphylococcus aureus—an Australian perspective. Eur. J. Clin. Microbiol. Infect. Dis. 24:100-108. - PubMed
-
- Howden, B. P., P. B. Ward, P. G. Charles, T. M. Korman, A. Fuller, P. du Cros, E. A. Grabsch, S. A. Roberts, J. Robson, K. Read, N. Bak, J. Hurley, P. D. Johnson, A. J. Morris, B. C. Mayall, and M. L. Grayson. 2004. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin. Infect. Dis. 38:521-528. - PubMed
-
- Tenover, F. C., and L. C. McDonald. 2005. Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr. Opin. Infect. Dis. 18:300-305. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
